A critical advance in cancer study is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This essential tumor protector protein is frequently inactivated in many forms of tumors, leading https://thegreatbookmark.com/story21955801/mini-antibodies-revive-the-p53-protein-a-promising-hope-for-malignant-treatment